相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular genetics of B-precursor acute lymphoblastic leukemia
Charles G. Mullighan
JOURNAL OF CLINICAL INVESTIGATION (2012)
Silencing of ETV6/RUNX1 abrogates PI3K/AKT/mTOR signaling and impairs reconstitution of leukemia in xenografts
G. Fuka et al.
LEUKEMIA (2012)
Somatic STAT3 Mutations in Large Granular Lymphocytic Leukemia
Hanna L. M. Koskela et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Prevalence of t(12;21)[ETV6-RUNX1]-positive cells in healthy neonates
Ulrik Lausten-Thomsen et al.
BLOOD (2011)
ETV6-RUNX1 promotes survival of early B lineage progenitor cells via a dysregulated erythropoietin receptor
Veronica Torrano et al.
BLOOD (2011)
Modeling the evolution of ETV6-RUNX1-induced B-cell precursor acute lymphoblastic leukemia in mice
Louise van der Weyden et al.
BLOOD (2011)
The R(h)oads to Stat3: Stat3 activation by the Rho GTPases
Leda Raptis et al.
EXPERIMENTAL CELL RESEARCH (2011)
Genetic variegation of clonal architecture and propagating cells in leukaemia
Kristina Anderson et al.
NATURE (2011)
Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells
Faiyaz Notta et al.
NATURE (2011)
The Leukemia-Specific Fusion Gene ETV6/RUNX1 Perturbs Distinct Key Biological Functions Primarily by Gene Repression
Gerhard Fuka et al.
PLOS ONE (2011)
TEL-AML1 regulation of survivin and apoptosis via miRNA-494 and miRNA-320a
Christofer Diakos et al.
BLOOD (2010)
STAT5 in B cell development and leukemia
Stephen Malin et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
The RAC specific guanine nucleotide exchange factor Asef functions downstream from TEL-AML1 to promote leukaemic transformation
Ruth Lyons et al.
LEUKEMIA RESEARCH (2010)
ETV6/RUNX1 abrogates mitotic checkpoint function and targets its key player MAD2L1
G. Krapf et al.
ONCOGENE (2010)
TEL-AML1 Corrupts Hematopoietic Stem Cells to Persist in the Bone Marrow and Initiate Leukemia
Jeffrey W. Schindler et al.
CELL STEM CELL (2009)
Rho GTPases in hematopoietic stem cell functions
Jose A. Cancelas et al.
CURRENT OPINION IN HEMATOLOGY (2009)
Targeting Signal Transducer and Activator of Transcription Signaling Pathway in Leukemias
Mustafa Benekli et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
JAK mutations in high-risk childhood acute lymphoblastic leukemia
Charles G. Mullighan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Discovery of chromone-based inhibitors of the transcription factor STAT5
Judith Mueller et al.
CHEMBIOCHEM (2008)
Role of the Erythropoietin Receptor in ETV6/RUNX1-Positive Acute Lymphoblastic Leukemia
Andrea Inthal et al.
CLINICAL CANCER RESEARCH (2008)
Acute lymphoblastic leukaemia
Ching-Hon Pui et al.
LANCET (2008)
Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia
Dengli Hong et al.
SCIENCE (2008)
STAT3 as a central mediator of neoplastic cellular transformation
David A. Frank
CANCER LETTERS (2007)
TEL-AML1 preleukemic activity requires the DNA binding domain of AML1 and the dimerization and corepressor binding domains of TEL
M. Morrow et al.
ONCOGENE (2007)
Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity
Khandaker Siddiquee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
RNAi-mediated silencing of TEL/AML1 reveals a heat-shock protein- and survivin-dependent mechanism for survival
Christofer Diakos et al.
BLOOD (2007)
STAT3 positively regulates an early step in B-cell development
Wei-Chun Chou et al.
BLOOD (2006)
Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute consortium protocol 95-01
Mignon L. Loh et al.
BLOOD (2006)
Survivin, a cancer target with an emerging role in normal adult tissues
Seiji Fukuda et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Incidence of additional genetic changes in the TEL and AML1 genes in DCOG and COALL-treated t(12;21)-positive pediatric ALL, and their relation with drug sensitivity and clinical outcome
WAG Stams et al.
LEUKEMIA (2006)
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity
M Kortylewski et al.
NATURE MEDICINE (2005)
Defining the oncogenic function of the TEL/AML1 (ETV6/RUNX1) fusion protein in a mouse model
M Fischer et al.
ONCOGENE (2005)
Selective activation of STAT5 unveils its role in stem cell self-renewal in normal and leukemic hematopoiesis
Y Kato et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice
S Tsuzuki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Rational design and characterization of a Rac GTPase-specific small molecule inhibitor
Y Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
TEL-AML1 promotes development of specific hematopoietic lineages consistent with preleukemic activity
M Morrow et al.
BLOOD (2004)
Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia
ML Den Boer et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Constitutive and specific activation of STAT3 by BCR-ABL in embryonic stem cells
P Coppo et al.
ONCOGENE (2003)
Rho GTPases in cell biology
S Etienne-Manneville et al.
NATURE (2002)
Chromosome translocations and covert leukemic clones are generated during normal fetal development
H Mori et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
分享论文
